Human stromal cells are required for an anti-breast cancer effect of zoledronic acid

Por Nienhuis, Hilde H., Arjaans, Marlous, Timmer-Bosscha, Hetty, de Vries, Elisabeth G.E., Schröder, Carolina P.
Publicado no Oncotarget (2015)

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

Por Arjaans, Marlous, Schröder, Carolina P., Oosting, Sjoukje F., Dafni, Urania, Kleibeuker, Josée E., de Vries, Elisabeth G.E.
Publicado no Oncotarget (2016)